|
|
|
MIRA INFORM REPORT
|
Report No. : |
486280 |
|
Report Date : |
25.01.2018 |
IDENTIFICATION DETAILS
|
Name : |
FAME PHARMACEUTICALS INDUSTRY CO., LTD. |
|
|
|
|
Formerly Known As : |
FAME PHARMACEUTICALS CO., LTD. |
|
|
|
|
Registered Office : |
No. 20, Mingyi
Mahar Min Gaung Road, Industrial
Zone (3), Hlaing Thar Yar City of Industry,
11401 Hlaing Thar Yar Township, Yangon |
|
|
|
|
Country : |
Myanmar |
|
|
|
|
Date of Incorporation : |
01.01.1994 |
|
|
|
|
Com. Reg. No.: |
609/1994-1995 |
|
|
|
|
Legal Form : |
Limited Liability Company |
|
|
|
|
Line of Business : |
· Manufacture of Basic Pharmaceutical Products · Wholesale of Pharmaceutical Goods |
|
|
|
|
No. of Employees : |
250-399 [2018] |
RATING & COMMENTS
(Mira Inform has adopted New Rating mechanism w.e.f. 23rd
January 2017)
|
MIRA’s Rating : |
B |
|
Credit Rating |
Explanation |
Rating Comments |
|
B |
Medium Risk |
Business dealings permissible on a regular
monitoring basis |
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Unknown |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List
|
Country Name |
Previous Rating (30.06.2017) |
Current Rating (30.09.2017) |
|
Myanmar |
B1 |
B1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderately Low Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderately High Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
Company
Summary
|
|
|
Business Name |
FAME PHARMACEUTICALS INDUSTRY CO., LTD. |
|
Country |
MYANMAR |
|
Company Registration Number |
609/1994-1995 |
|
Main Activity Code |
2110 |
|
Main Activity Description |
Manufacture of basic pharmaceutical products |
|
Company Status |
Active (Active) |
|
Latest Turnover Figure |
- |
|
Latest Shareholder Equity Figure |
- |
Basic
Information
|
|
|
Business Name |
FAME PHARMACEUTICALS INDUSTRY CO., LTD. |
|
Registered Company Name |
FAME PHARMACEUTICALS INDUSTRY CO., LTD. |
|
Company Registration Number |
609/1994-1995 |
|
Country |
MYANMAR |
|
VAT Registration Number |
|
|
VAT Registration Date |
|
|
Date of Company Registration |
1994-09-06 |
|
Date of Starting Operations |
1994-01-01 |
|
Commercial Court |
|
|
Legal Form |
Limited Liability Company |
|
Type of Ownership |
|
|
Company Status |
Active (Active) |
|
Principal Activity Code |
|
|
Principal Activity Description |
|
|
Contact Telephone Number |
95 1685 083, 95 1682 199 |
Main
Address
|
||
|
Address |
Country |
Telephone |
|
No. 20, Mingyi
Mahar Min Gaung Road, Industrial
Zone (3), Hlaing Thar Yar City of Industry,
11401 Hlaing Thar Yar Township, Yangon |
MYANMAR |
95 1685 083, 95 1682 199 |
Other
Address
|
|
No other addresses for this company. |
Previous
Address
|
|
No previous addresses for this company. |
Activities
|
|
|
Activity Code |
Activity Description |
|
2110 |
Manufacture of basic pharmaceutical products |
|
4646 |
Wholesale of pharmaceutical goods |
Email
Addresses
|
Web
Pages
|
Previous
Names
|
|
Previous Name Date Changed from Previous Name |
|
Fame Pharmaceuticals Co., Ltd. |
Employee
Information
|
|
Date Reported Number of Employees |
|
2018 250-399 |
Banker
Information
|
|
Banker Name Banker Address Phone Number |
|
No banker information for this company. |
Advisors
Information
|
|
No advisor information for this company. |
Miscellaneous
Information
|
|
|
Fax Number |
95 1680 122 |
|
Export Countries |
|
|
Import Countries |
|
|
Additional Business Information |
The company is engaged in manufacture of herbal medicinal
products: Natural , Organic and Raw Products. The company is a member of UN
Global Compact since 2014. |
|
Additional Rating Information |
Credit to the recommended limit should be
acceptable but should be monitored on a regular basis. |
|
Additional Payment Information |
No payment history is available. |
|
Additional Financial Information |
Private companies are not required to publish or
disclose balance sheets. Balance sheets are not available from other sources. |
|
Number of Employees at Address |
250-399 |
|
Number of Employees at Group |
|
|
Number of Employees at Factory |
|
Additional
Miscellaneous Information
|
|
|
Comments about your request |
The company's complete and correct name is Fame Pharmaceuticals
Industry Co., Ltd.. Please find the company's
complete and correct address in this report. We were not able to reach the
person in charge that can provide us information. We will send an update if
we are able to contact them. We sent a questionnaire to the email
available requesting more
information from the
company but we did not
receive a reply. |
|
Line of Business |
Pharmaceutics, Consumer goods wholesale. |
|
Industry Division |
Manufacturing, Wholesale trade. |
|
Responsible Register |
Directorate of Investment and Company
Administration. |
|
Remarks |
Duration: April 25, 2020 (expiry date for the
oficial registry). |
|
Sanctions List |
We did not find the company included on the
various international sanctions lists, such as the OFAC (Office of Foreign
Assets Control), the BIS (Bureau of Industry and Security), the European
Union Restrictive measures (sanctions) list, the Export Control Organisation
(ECO) of the UK, the Australian Department of Foreign Affairs and Trade. |
|
Owners |
Names of the shareholders are not available. |
|
Main Activities |
The company is engaged in manufacture of herbal
medicinal products: Natural , Organic and Raw Products. The company is a
member of UN Global Compact since 2014. |
|
Quality certification |
ISO 14001:2004 - since 2007; OHSAS 18001:2007
- since 2007; ISO 9001:2015; GMP certificate - since 2002;
Organic certified - since 2010; USDA (United States Department of
Agriculture) - since 2013; ACO (Australian Certified Organic) - since
2013. |
|
Companys Background |
The company has changed its name from Fame Pharmaceuticals Co., Ltd. to Fame Pharmaceuticals Industry Co., Ltd.,
however we were unable to obtain in the official registry when that change
occurred. In 2010, Dr. Khin Maung
Lwin, Managing Director and founder of FAME Pharmaceuticals founded the FAME Clinic. Dr. Khin Maung Lwin practices the combination of
“Western” (Conventional) medicine and “Eastern” (Complementary and
Alternative) medicine treatments approach to treat patients with health problems
associated with the central nervous, respiratory, cardiovascular, urological,
bone, cancer, liver and kidney disease, diabetics, hormonal imbalance,
several types of skin infections diseases. |
Financial
Information
|
|
No financial information for this company. |
Current
Directors
|
||
|
Name |
Gender |
Position |
|
Khin Htay, Khin |
Unknown |
Director |
|
Kyaw Thaung, Moe |
Unknown |
Director |
|
Maung Lwin, Khin |
Unknown |
Chief Executive Officer |
Previous
Directors
|
|
No previous directors for this company. |
Share
Capital Structure
|
|
No share capital information for this company |
Group
Structure
|
|
No group structure information for this company |
Negative
Information
|
|
Public information: No legal actions determined. |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
INR 63.64 |
|
|
1 |
INR 89.32 |
|
Euro |
1 |
INR 78.45 |
|
MMK |
1 |
INR 0.048 |
Note :
Above are approximate rates obtained from sources believed to be correct
INFORMATION DETAILS
|
Analysis Done by
: |
DIV |
|
|
|
|
Report Prepared
by : |
TPT |
RATING EXPLANATIONS
|
Credit Rating |
Explanation |
Rating Comments |
|
A++ |
Minimum Risk |
Business dealings permissible with minimum
risk of default |
|
A+ |
Low Risk |
Business dealings permissible with low
risk of default |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
B |
Medium Risk |
Business dealings permissible on a regular
monitoring basis |
|
C |
Medium High Risk |
Business dealings permissible preferably
on secured basis |
|
D |
High Risk |
Business dealing not recommended or on
secured terms only |
|
NB |
New Business |
No recommendation can be done due to
business in infancy stage |
|
NT |
No Trace |
No recommendation can be done as the
business is not traceable |
NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors are as follows:
·
Financial
condition covering various ratios
·
Company
background and operations size
·
Promoters
/ Management background
·
Payment
record
·
Litigation
against the subject
·
Industry
scenario / competitor analysis
·
Supplier
/ Customer / Banker review (wherever available)
This report is issued at
your request without any risk and responsibility on the part of MIRA INFORM
PRIVATE LIMITED (MIPL) or its officials.